Article

Aberrometer receives CE Mark

The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.

Milan, Italy-The iDesign Advanced WaveScan Studio aberrometer, a next-generation diagnostic tool for mapping and analyzing corneal aberrations in the eye for wavefront-guided LASIK procedures, has been awarded a CE Mark, according to Abbott, the device’s manufacturer.

The system makes an individual “blueprint” of the eyes, maps imperfections, and creates a treatment plan. After a corneal flap is created using the iFS femtosecond laser, the treatment plan is executed using the STAR S4 IR excimer laser system, providing computer-driven custom correction for each patient.

"The approval of the [aberrometer] in Europe further enhances the three-step iLASIK process to set a new standard for laser vision correction," said Jim Mazzo, senior vice president, Abbott Medical Optics.

The system offers high-definition measurements and state-of-the-art technology benefits including:

Precise alignment for more accurate, customized corneal and wavefront measurement;

Five diagnostic ocular measurements within a single capture sequence that determine the eye’s refractive error, wavefront error, corneal topography and curvature, and pupil size, providing a more efficient workflow for the physician;

A higher-definition wavefront sensor that can detect and map highly aberrated corneas, maximizing ocular capture rates and potentially expanding the pool of patients who may qualify for wavefront-guided LASIK procedures; and

Improved ease-of-use for the physician through an enhanced graphical interface with advanced video target aids and onscreen tools.

Clinical trials to support registration for the aberrometer have recently commenced at several sites across the United States.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.